AAD Faculty interviews

 
Recent developments in topical and systemic treatments for acne
 
36
How common is acne, and what burden does it place on patients?
92
Traditionally, what have been the treatment options for acne?
135
What advances have been seen in topical treatments?
391
What are the main advantages and disadvantages of systemic treatments?
 
What’s new in dermatologic surgery and cosmetic dermatology
 
38
How has the COVID-19 pandemic affected dermatologic surgery and cosmetic dermatology?
313
What do you think is the single most important advance in dermatologic surgery made in recent years?
405
And what about cosmetic dermatology?
 
Controversies in rosacea
 
33
The National Rosacea Society released updated criteria for diagnosis of rosacea. You have been a critic of the prior diagnostic criteria from this group, do you feel this publication has a positive impact?
135
I know you have concerns. How do they translate into negative consequences in patient care?
385
The same group also published an article on standard management of rosacea last year. Do you agree with their recommendations?
522
Can you tell us about a couple of new studies you find exciting regarding possible therapeutic innovations?
 
JAK Inhibitors: The Next Frontier in Dermatology
 
34
How has understanding of immunological processes changed dermatology practice?
114
What are the current and future indications for JAK inhibitors?
305
What are the advantages of topical JAK inhibitors?
 
Photoprotection in people of color
 
52
What common misconceptions are there about photoprotection in people of color?
215
How does prevalence and prognosis of skin cancer compare in people of color compared to those with white skin?
308
How can we educate people on the need to protect skin of all colors?
490
What should people look for when checking their own skin?
 
Pemphigus - Diagnosis, evaluation and management
 
40
How often do you see patients with pemphigus?
127
What are the risk factors for pemphigus?
390
Are there any useful tools for evaluating and classifying the severity of pemphigus?
614
Are there any recent national attempts to standardize the diagnosis and management of pemphigus?

 

 
Off-label use of biologics and new medications
 
54
What are the on-label uses for biologics?
113
What are the most common off-label uses for biologics?
189
What drives the decision to use a medicine off-label?
351
Are dermatologists using targeted small molecules off-label too?
420
How do you look for efficacy and safety information?
504
How can a medication move from off-label to on-label?
 
Telemedicine
 
63
What is telemedicine?
228
What tools can be used in telemedicine?
372
How can telemedicine help in the area of dermatology surgery?
652
How are you going to charge patients if you are just doing something like this?
792
What recommendations would you give for setting up a telemedicine practice?

 

Post test Go to the VMX Feedback